Health economic model of smoking cessation treatment with varenicline in Germany

Rasch A, Lenz C, Greiner W (2007)
Value in Health 10(6): A472-A473.

Download
No fulltext has been uploaded. References only!
Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ;
Publishing Year
ISSN
PUB-ID

Cite this

Rasch A, Lenz C, Greiner W. Health economic model of smoking cessation treatment with varenicline in Germany. Value in Health. 2007;10(6):A472-A473.
Rasch, A., Lenz, C., & Greiner, W. (2007). Health economic model of smoking cessation treatment with varenicline in Germany. Value in Health, 10(6), A472-A473. doi:10.1016/S1098-3015(10)65623-9
Rasch, A., Lenz, C., and Greiner, W. (2007). Health economic model of smoking cessation treatment with varenicline in Germany. Value in Health 10, A472-A473.
Rasch, A., Lenz, C., & Greiner, W., 2007. Health economic model of smoking cessation treatment with varenicline in Germany. Value in Health, 10(6), p A472-A473.
A. Rasch, C. Lenz, and W. Greiner, “Health economic model of smoking cessation treatment with varenicline in Germany”, Value in Health, vol. 10, 2007, pp. A472-A473.
Rasch, A., Lenz, C., Greiner, W.: Health economic model of smoking cessation treatment with varenicline in Germany. Value in Health. 10, A472-A473 (2007).
Rasch, A., Lenz, C., and Greiner, Wolfgang. “Health economic model of smoking cessation treatment with varenicline in Germany”. Value in Health 10.6 (2007): A472-A473.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar